Treating bone-related disorders with selective androgen receptor modulators

Details for Australian Patent Application No. 2004281708 (hide)

Owner University of Tennessee Research Foundation

Inventors Dalton, James; Steiner, Mitchell S.; Veverka, Karen A.; Miller, Duane D.; Kearby, Jeffrey

Agent Griffith Hack

Pub. Number AU-B-2004281708

PCT Pub. Number WO2005/037201

Priority 60/613,206 28.09.04 US; 60/510,138 14.10.03 US

Filing date 12 October 2004

Wipo publication date 28 April 2005

Acceptance publication date 17 February 2011

International Classifications

A61K 31/167 (2006.01) - having the nitrogen atom of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol

A61P 19/00 (2006.01) Drugs for skeletal disorders

A61P 19/08 (2006.01) Drugs for skeletal disorders

A61P 19/10 (2006.01) Drugs for skeletal disorders

Event Publications

12 January 2006 PCT application entered the National Phase

  PCT publication WO2005/037201 Priority application(s): WO2005/037201

17 February 2011 Application Accepted

  Published as AU-B-2004281708

16 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004281721-Cassette for handling and holding tissue samples during processing, embedding and microtome procedures, and methods therefor

2004281707-Composition comprising xanthoceras sorbifolia extracts, compounds isolated from same, methods for preparing same and uses thereof